Harmony Biosciences Holdings (HRMY) Earnings Date & Reports

A.I. Advisor

published Earnings

HRMY is expected to report earnings to fall 36.67% to 66 cents per share on October 29

Harmony Biosciences Holdings HRMY Stock Earnings Reports

Q3'24

Est.

$0.67

Q2'24

Beat

by $1.04

Q1'24

Beat

by $0.25

Q4'23

Beat

by $0.01

Q3'23

Beat

by $0.30

The last earnings report on August 06 showed earnings per share of $1.05, beating the estimate of 0 cents. With 487.74K shares outstanding, the current market capitalization sits at 2.22B.

View a ticker or compare two or three

Compare

HRMY

Setup

Buy or SellView

Daily Signalchanged days ago

Gain/Loss if shorted

View Trends For HRMY
(Try 14 days for $1 only)

Ad is loading...

A.I.Advisor

published price charts

View to see Real Time Patterns for HRMY (Try 14 days for $1 only)

A.I. Advisor

published General Information

General Information

a commercial-stage pharmaceutical company, which engages in the development and commercialization of therapies for the treatment of neurological disorders

Industry Biotechnology

Profile

Fundamentals

Details

Industry

N/A

Address

630 West Germantown Pike

Phone

+1 484 539-9800

Employees

246

Web

https://www.harmonybiosciences.com